Albumin replacement therapy targeting serum levels ≥ 3.0 g/dL does not improve 90-day survival in patients with septic shock in the emergency department, a trial shows.

A 76-year-old male was admitted in June 2025 due to nausea, poor appetite, and fatigue for one month. History of Present Illness: In May 2025, the patient experienced unexplained poor appetite, nausea ...